Literature DB >> 4556192

Biochemical studies and therapy in subacute necrotizing encephalomyelopathy (Leigh's syndrome).

W D Grover, V H Auerbach, M S Patel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4556192     DOI： 10.1016/s0022-3476(72)80371-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  14 in total

1.  Leigh's disease: significance of the biochemical changes in brain.

Authors:  J V Murphy; L Craig
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-11       Impact factor: 10.154

2.  Biochemical study in 28 children with lactic acidosis, in relation to Leigh's encephalomyelopathy.

Authors:  S Miyabayashi; T Ito; K Narisawa; K Iinuma; K Tada
Journal:  Eur J Pediatr       Date:  1985-03       Impact factor: 3.183

3.  Hepatic glycogen synthetase deficiency.

Authors: 
Journal:  Arch Dis Child       Date:  1973-02       Impact factor: 3.791

Review 4.  The biotin-dependent carboxylase deficiencies.

Authors:  B Wolf; G L Feldman
Journal:  Am J Hum Genet       Date:  1982-09       Impact factor: 11.025

5.  Studies on cultured fibroblasts from patients with defects of biotin-dependent carboxylation.

Authors:  K Bartlett; H Ng; G Dale; A Green; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1981       Impact factor: 4.982

6.  Leigh's disease with decreased activities of pyruvate carboxylase and pyruvate decarboxylase.

Authors:  J P Van Biervliet; M Duran; S K Wadman; J F Koster; A van Rossum
Journal:  J Inherit Metab Dis       Date:  1980       Impact factor: 4.982

7.  Megavitamin therapy in inherited metabolic disorders.

Authors:  S C Kalhan
Journal:  Indian J Pediatr       Date:  1981 Sep-Oct       Impact factor: 1.967

8.  Neonatal pyruvate carboxylase deficiency with renal tubular acidosis and cystinuria.

Authors:  J Oizumi; K N Shaw; T A Giudici; M Carter; G N Donnell; W G Ng
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

9.  Hepatic, gut, and renal substrate flux rates in patients with hepatic cirrhosis.

Authors:  O E Owen; F A Reichle; M A Mozzoli; T Kreulen; M S Patel; I B Elfenbein; M Golsorkhi; K H Chang; N S Rao; H S Sue; G Boden
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

10.  Hyperalaninemia hyperpyruvicemia and lactic acidosis due to pyruvate carboxylase deficiency of the liver; treatment with thiamine and lipoic acid.

Authors:  H Maesaka; K Komiya; K Misugi; K Tada
Journal:  Eur J Pediatr       Date:  1976-05-04       Impact factor: 3.183
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.